(VIANEWS) – GRIEG SEAFOOD (GSF.OL), UCB (UCB.BR), TKH GROUP (TWEKA.AS) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. GRIEG SEAFOOD (GSF.OL)
218.75% Payout Ratio
Grieg Seafood ASA, through its subsidiaries, operates as a fish farming company in Norway, the United Kingdom, rest of Europe, the United States, Canada, Asia, and internationally. It engages in the farming, production, and sale of Atlantic salmon. The company was incorporated in 1988 and is headquartered in Bergen, Norway. Grieg Seafood ASA is a subsidiary of Grieg Aqua AS.
Earnings Per Share
As for profitability, GRIEG SEAFOOD has a trailing twelve months EPS of kr0.8.
PE Ratio
GRIEG SEAFOOD has a trailing twelve months price to earnings ratio of 78.38. Meaning, the purchaser of the share is investing kr78.38 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.84%.
Volume
Today’s last reported volume for GRIEG SEAFOOD is 160224 which is 61.23% below its average volume of 413301.
More news about GRIEG SEAFOOD.
2. UCB (UCB.BR)
111.48% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.22.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 140.45. Meaning, the purchaser of the share is investing €140.45 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.67%.
More news about UCB.
3. TKH GROUP (TWEKA.AS)
58.22% Payout Ratio
TKH Group N.V. develops and delivers smart vision, smart manufacturing, and smart connectivity systems in the Netherlands, Europe, Asia, North America, and internationally. The Smart Vision Systems segment provides 2D and 3D machine vision used to enhance quality inspection, operation, and object monitoring; and security vision technologies that enable customers to manage and control the urban environment, as well as enhances efficiency, safety, and security in various markets, such as infrastructure, parking, and building security. This segment serves various industries, such as consumer electronics, factory automation, logistics, wood, intelligent transport systems, medical, and life sciences. The Smart Manufacturing Systems segment offers systems engineering and assembly, control and analysis software, and connectivity and vision technologies to car and truck tire production, and factory automation industries; and care solutions, including medicine distribution machines. The Smart Connectivity Systems segment develops connectivity systems for on-shore and off-shore energy distribution; fiber optic connectivity systems for data and communication networks; and specialized cable systems for various industrial automation applications, such as the industrial, marine and offshore, and medical sectors, as well as provides contactless energy and data distribution comprising hardware components and intelligent software for airfield ground lighting systems. The company was formerly known as NV Twentsche Kabel Holding and changed its name to TKH Group N.V. in 2005. TKH Group N.V. was incorporated in 1980 and is based in Haaksbergen, the Netherlands.
Earnings Per Share
As for profitability, TKH GROUP has a trailing twelve months EPS of €2.92.
PE Ratio
TKH GROUP has a trailing twelve months price to earnings ratio of 12.84. Meaning, the purchaser of the share is investing €12.84 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.44%.
Sales Growth
TKH GROUP’s sales growth for the next quarter is 0.1%.
More news about TKH GROUP.
4. SEMAPA (SEM.LS)
43.74% Payout Ratio
Semapa – Sociedade de Investimento e Gestão, SGPS, S.A., through its subsidiaries, produces and sells uncoated woodfree (UWF) printing and writing paper in Portugal, rest of Europe, the United States, Africa, Asia, and Oceania. It operates through Pulp and Paper, Cement and Derivatives, and Other Businesses segments. The company produces and sells writing, printing thin paper, and tissue paper; researches, develops, produces, and sells forestry and agricultural products; produces and sells bleached eucalyptus kraft pulp (BEKP), cork, and pine wood products; and produces and sells energy from thermal, natural gas, and biofuel sources. It is also involved in the production and sale of cement, ready-mixed concrete, aggregates, mortars, prefabricated concrete structures, hydraulic lime, and clinker products; and operation of quarries. In addition, the company engages in the production of e-bike frames; and provision of services related to recovery of animal by-products and food products containing animal origin substances to produce fertilizers, animal feed, and biodiesel. The company was incorporated in 1991 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, SEMAPA has a trailing twelve months EPS of €3.36.
PE Ratio
SEMAPA has a trailing twelve months price to earnings ratio of 4.48. Meaning, the purchaser of the share is investing €4.48 for every euro of annual earnings.
More news about SEMAPA.
5. GLINTT (GLINT.LS)
32.23% Payout Ratio
Glintt Global, S.A. provides IT consulting services for banking, insurance, public administration, and utilities sectors in Portugal, Spain, and Angola. It operates through two segments: Health and Other Markets. The company engages in the sale of equipment, furniture, consumables, and robotics solutions; development of architectural projects; and design and conception of lay-out and image for pharmacies, training, equipment maintenance, and consultancy projects. It licenses proprietary software solutions for healthcare providers, such as clinics, hospitals, pharmacies, and other bodies of the ministry of health; and develops, implements, and maintains software services for the health sector. In addition, the company implements ERPs, integrates internet systems, and develops tailor-made applications services. Further, the company develops, implements, and integrates partner platforms with emphasis on the BPM, ERP, BI and mobility solutions; and integrates IT infrastructures, as well as support for networking, security, storage systems, and database management. The company was formerly known as Glintt – Global Intelligent Technologies, S.A. and changed its name to Glintt Global, S.A. in July 2024. Glintt Global, S.A. was incorporated in 1995 and is based in Sintra, Portugal. Glintt Global, S.A. operates as a subsidiary of Farminveste – Investimentos, Participações E Gestão S.A.
Earnings Per Share
As for profitability, GLINTT has a trailing twelve months EPS of €0.05.
PE Ratio
GLINTT has a trailing twelve months price to earnings ratio of 10. Meaning, the purchaser of the share is investing €10 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.67%.
Moving Average
GLINTT’s worth is higher than its 50-day moving average of €0.49 and way above its 200-day moving average of €0.42.
Yearly Top and Bottom Value
GLINTT’s stock is valued at €0.50 at 12:10 EST, below its 52-week high of €0.53 and way above its 52-week low of €0.30.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 25, 2024, the estimated forward annual dividend rate is 0.03 and the estimated forward annual dividend yield is 7.1%.
Volume
Today’s last reported volume for GLINTT is 17800 which is 59.18% above its average volume of 11182.
More news about GLINTT.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
Sales Growth
1’s sales growth is 1% for the current quarter and 1% for the next.
More news about 1.
